Results 101 to 110 of about 367,353 (219)

Maxillofacial metastasis of genitourinary origin. A report of 3 cases and review of the literature [PDF]

open access: yes, 2012
Introduction: The maxillofacial region can harbour a wide range of primary tumours, as well as secondary tumours spreading from distant sites. Rare, though nevertheless important among the latter are genitourinary tumours, such as clear cell renal ...
Acosta Moyano, A.   +6 more
core   +1 more source

Immunotherapy of Clear-Cell Renal-Cell Carcinoma

open access: yesCancers
Clear-cell Renal-Cell Carcinoma (ccRCC) is the most common type of renal-cell carcinoma (RCC). In many cases, RCC patients manifest the first symptoms during the advanced stage of the disease. For this reason, immunotherapy appears to be one of the dominant treatments to achieve a resolution.
Sophie Grigolo, Luis Filgueira
openaire   +2 more sources

RECURRENT RENAL CARCINOMA MIMICKING A GOITRE: A CASE REPORT [PDF]

open access: yes, 2013
Although the thyroid is a high vascularised gland, it is not common terget of metastases from extraglandular cancer. We reported a case of a 70 year-old woman who underwnt total thyroidectomy for multinodular goitre.
ABRUZZO, Alida   +11 more
core  

Marker Genes of Clear Cell Renal Cell Carcinoma

open access: yesJournal of Education, Health and Sport
An analysis was conducted on marker genes indicating the induction of clear cell renal cell carcinoma (ccRCC) and their role in the pathogenesis of this oncological disease.
Sergey Dolomatov, Walery Zukow
doaj   +1 more source

PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation [PDF]

open access: yes, 2017
Renal cell carcinoma (RCC) is one of the most aggressive urologic cancers, however, the mechanism on supporting RCC carcinogenesis is still not clear.
Feng, D   +11 more
core   +2 more sources

Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma

open access: yesTumor Biology, 2017
Beta-1,4-galactosyltransferase II is found to be associated with the alterations of tumor-related glycosylation. However, the clinical significance of beta-1,4-galactosyltransferase II in non-metastatic clear-cell renal cell carcinoma has not been ...
Haijian Zhang   +9 more
doaj   +1 more source

Novel noninvasive marker of regression of clear cell renal cell carcinoma (ccRCC)

open access: yesTurkish Journal of Urology, 2022
Barbara Köditz   +3 more
doaj   +1 more source

The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one [PDF]

open access: yes, 2018
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice.
Botticelli, A.   +4 more
core   +1 more source

Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. [PDF]

open access: yes, 2017
Intratumoral heterogeneity (ITH) is a prominent feature of kidney cancer. It is not known whether it has utility in finding associations between protein expression and clinical parameters. We used ITH that is detected by immunohistochemistry (IHC) to aid
Devarajan, Karthik   +10 more
core   +3 more sources

CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p

open access: yesMolecular Cancer, 2019
Clear cell renal cell carcinoma (CCRCC) is characterized by a highly metastatic potential. The stromal communication between stem cells and cancer cells critically influences metastatic dissemination of cancer cells.
Lu Wang   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy